Mycosis fungoides (MF) is a relatively rare non-Hodgkin\'s lymphoma arising from extranodal tissue. It is the most common type of cutaneous T-cell lymphoma (CTCL), characterised by a typically slow evolution and protracted course. Although previous epidemiological studies had shown its increasing incidence ([Weinstock and Horm, 1988](#bib57){ref-type="other"}), this could be an artefact caused by improved diagnostic techniques ([Morales Suarez-Varela *et al*, 2000](#bib28){ref-type="other"}). Despite a number of studies, the aetiology of this disease still remains to be determined. Postulated mechanisms include the persistence of viral or bacterial agents that could exacerbate and/or stimulate chronic T-cell clonal expansion and cutaneous inflammation ([Siegel *et al*, 2000](#bib50){ref-type="other"}; [Fierro *et al*, 2001](#bib9){ref-type="other"}).

Borrelia burgdorferi (Bb) is the aetiologic agent of Lyme disease (LD), the most common tick-transmitted disease in the northern hemisphere ([Jaenson, 1991](#bib16){ref-type="other"}). It is a multisystem inflammatory disorder, which affects skin, nervous system, cardiovascular system, joints, muscles and eyes ([Scarpa *et al*, 1994](#bib45){ref-type="other"}). About 80% of all LD cases in Europe present cutaneous symptoms (dermatoborrelioses) ([Mullegger, 2004](#bib29){ref-type="other"}). Erythema migrans, borrelial lymphocytoma and acrodermatitis chronica atrophicans are three characteristic dermatoborrelioses, occurring in different clinical stages of the disease, but borrelial isolation has also been reported from lesional tissues of various cutaneous disorders ([Mullegger, 2004](#bib29){ref-type="other"}).

The aim of the present study was to evaluate the role of Bb in pathogenesis of MF in the LD-endemic region of Friuli Venezia Giulia (FVG) in Northeastern Italy ([Ciceroni and Ciarrocchi, 1998](#bib5){ref-type="other"}). We analysed skin biopsies of MF patients for the presence of the specific Bb genome using a highly sensitive polymerase chain reaction (PCR) method ([Lebech, 2002](#bib24){ref-type="other"}).

MATERIALS AND METHODS
=====================

This study included 83 patients with a clinical diagnosis of MF, who were diagnosed between 1993 and 2003 at the Dermatology Unit of The University of Trieste in Italy. Clinical data analysed in this study included age, sex, stage of disease, extracutaneous tumour involvement and disease duration at the moment of the histological diagnosis. The study was conducted according to the Declaration of Helsinki protocols. Lesional tissue biopsies were reviewed by two dermatopathologists (GG and GS), and classified according to the criteria of the WHO classification of malignant lymphoma ([Jaffe, 2001](#bib17){ref-type="other"}) after precise immunohistochemical evaluation. In all cases, the diagnosis of MF was established by clinico-histopathological correlation between dermatologist GT and dermatopathologists GG and GT. Immunostaining was performed on paraffin-embedded tissue sections in all 83 MF cases using monoclonal antibodies specific for T-cell-associated antigens (CD3, CD4 and CD8) and for B-cell-associated antigens (CD20) and plasma cells.

Formalin-fixed and paraffin-embedded tissues of skin biopsies from 83 MF patients were examined for the presence of Bb genome. As controls we used surgical excisions of homolocalised naevi with the surrounding skin (63 dermal nevi, eight junctional nevi, six compound nevi and six blue nevi) of 83 healthy subjects, matched for age, sex and skin location.

Total DNA was extracted from 10 *μ*m sections of paraffin-embedded tissue blocks using a phenol--chloroform method ([Pauluzzi *et al*, 2004](#bib36){ref-type="other"}). We avoided a nested PCR because of the high risk of carryover related to this method. As the DNA extracted from formalin-fixed and paraffin-embedded tissues is partially degraded, we decreased the amplicon size to 75 bases and increased a number of amplification cycles to 70 in order to improve the sensitivity of the method (a high number of PCR cycles is suggested for paraffin-embedded tissue analysis) ([Lehmann and Kreipe, 2001](#bib25){ref-type="other"}; [Bonin *et al*, 2003](#bib3){ref-type="other"}). Primer sets were designed in low variability regions of the Borrelia chromosome. The primers targeted the gene that encodes flagellin, a 41 kDa protein (GenBank X16833) that is conserved in all European species of *Borrelia burgdorferi sensu lato* ([Schwaiger *et al*, 2001](#bib46){ref-type="other"}). Amplification employed bp 775--793 as the forward primer and bp 849--829 as the reverse primer. The sensitivity and specificity of the primers has previously been tested ([Pauluzzi *et al*, 2004](#bib36){ref-type="other"}). Every PCR reaction was run in duplicate under previously reported conditions ([Pauluzzi *et al*, 2004](#bib36){ref-type="other"}).

Pure genomic Bb DNA from *Borrelia afzelii, Borrelia garinii* and *Borrelia sensu stricto* and Bb positive tissues were used as positive controls. Formalin-fixed and paraffin-embedded biopsies of acrodermatitis chronica atrophicans and erythema migrans were used as tissue positive controls. As negative controls, we used paraffin blocks without tissue and Bb negative tissues, which were skin lesions positive for Mycobacterium tuberculosis. In the set-up of the method to assess its specificity, we analysed scrapes of primary syphilis, the DNA from *Mycobacetrium avium* and *Candida albicans*, as previously reported ([Pauluzzi *et al*, 2004](#bib36){ref-type="other"}). As additional critical controls, we have included 36 paraffin-embedded biopsies of B-cell pseudolymphomas.

Polymerase chain reaction products were confirmed by hybridisation with a ^32^P-labelled probe bp 801--828 internal to the amplicon, detected and counted using a Cyclon instrument (Packard) ([Pauluzzi *et al*, 2004](#bib36){ref-type="other"}).

In Bb positive cases a molecular analysis for the rearrangement of T-cell receptor-gamma (TCR-*γ*) gene was performed. T-cell receptor-gamma monoclonality was analysed using a PCR technique as described by [McCarthy *et al* (1992)](#bib27){ref-type="other"} and modified by Department of Dermatology, Medical University of Graz, Graz, Austria ([Massone *et al*, 2005](#bib26){ref-type="other"}). Polymerase chain reaction products were concentrated by precipitation and then resupended in 20 *μ*l of TE buffer 1 × . A 10 *μ*l aliquot of the PCR product was run on a 3.5% Metaphor agarose gel, stained with ethidium bromide and viewed under the UV light ([Massone *et al*, 2005](#bib26){ref-type="other"}). T-cell receptor-gamma gene rearrangements were considered monoclonal when one or two bands were produced within the expected size ranges (75--110 bases) ([McCarthy *et al*, 1992](#bib27){ref-type="other"}). As positive controls we used DNA extracted from Jurkat cells and DNA extracted from non-Hodgkin lymph nodes where a T-cell monoclonality has been previously assessed.

Statistical analysis was performed with dedicated STATASE8 software (Stata Corporation, TX, USA). The statistical significance was evaluated by Fisher\'s exact test for a 2 × 2 contingency table (95% confidence intervals) and one-way analysis of variance (ANOVA) test. Kruskal--Wallis test was applied to compare age at diagnosis, sex and disease duration in MF patients positive and negative for Bb genome. Moreover, to estimate the joint effects of the above-mentioned covariates on disease duration, the data were analysed by fitting the Cox proportional hazards regression model. *P*-values of 0.05 or less were considered to indicate statistical significance.

RESULTS
=======

In total, 83 MF patients were enrolled in the study, and patient characteristics are shown in [Table 1](#tbl1){ref-type="table"}. Skin biopsies were taken from MF lesions localised in five cases on the head and neck, in 43 cases on the trunk, in nine cases on the upper extremities, in 14 cases on lower extremities, and 12 cases were of unspecified localisation. The majority of our patients (87%) presented with early-stage disease (IA--IIA). In total, 13% of our patients had late-stage disease (IIB--IVB). Duration of the disease varied from 6 months to 15 years, mean 3.5 years. Immunohistochemistry: all cases examined were uniformly positive for CD3 and CD4 antigens and uniformly negative for CD20 and plasma cell antigens, 75% of samples were also CD8 positive ([Figure 1](#fig1){ref-type="fig"}).

The most common histological finding in our cases consisted of a bandlike upper dermal infiltrate of lymphocytes, fibrosis of papillary dermis and the infiltration of lymphocytes into the epidermis (epidermotropism) in the form of either a single lymphocyte epidermotropism or Pautrier\'s microabscesses. Lymphocytes infiltrating epidermis showed atypical features such as hyperchromatic and convoluted or cerebriform nuclei ([Figure 1](#fig1){ref-type="fig"}).

Using a sensitive PCR method with specific primers confirmed by hybridisation with a ^32^P-labelled Borrelia flagellin gene region oligonucleotide probe, Bb-specific sequence was detected in 15 out of 83 lesional skin samples of patients with MF (18.1%), but in none out of 83 matched healthy controls. The difference in frequency was significant (*P*\<0.0001). In addition, six out of 36 of B-cell pseudolymphoma controls also tested positive for Bb genome analysis.

All the 15 MF samples positive for Bb genome were from patients that had early-stage disease. Seven out of 15 patients presented with stage IA disease, six had stage IB and two patients had stage IIA. The difference in stage between the group of Bb negative and Bb positive MF samples was not significant (*P*=0.99). No significant differences were detected between Bb positive and negative patients regarding age (*P*=0.313), sex (*P*=0.160) and disease duration (*P*=0.590). In the multivariate analysis, the analysed covariates (age, sex and Bb positive or negative results) did not have any effect on disease duration *P*=0.596).

In cases positive for the Bb genome, we analysed the TCR-*γ* gene rearrangements using PCR analysis. A monoclonal T-cell infiltrate was demonstrated in 12 out of 15 Bb positive cases (80%). In 10 cases, one band in the range of 80--85 bases was observed and in two cases two bands in the same range were found representing a biallelic rearrangement of the TCR-*γ* genes ([Figure 2](#fig2){ref-type="fig"}) ([McCarthy *et al*, 1992](#bib27){ref-type="other"}).

DISCUSSION
==========

We have demonstrated the presence of Bb-specific DNA within lesional skin biopsies of MF patients, implying that approximately 18% of MF cases in this geographic area are perhaps related to infection with this organism. Despite LD being endemic in this region of FVG in Northeastern Italy ([Ciceroni and Ciarrocchi, 1998](#bib5){ref-type="other"}), we have shown that this association is highly significant, since Bb DNA was not found in any of our healthy control subjects.

To confirm the diagnosis of MF we analysed the TCR-*γ* gene rearrangements using PCR analysis. The finding of identical (clonal) TCR-*γ* gene rearrangements in cutaneous T lymphocytes indicates a malignant proliferation and differs them from a non-clonal (reactive) T-cell infiltration. Thus, detection of clonal TCR-*γ* gene rearrangements by PCR is a valuable tool for the diagnosis of cutaneous or other T-cell lymphomas. Out of 15 Bb positive cases, 12 were found to be positive for the clonal rearrangements of TCR-*γ* chain gene. The percentage of positive cases (80%) for the TCR-*γ* gene rearrangement agrees with other studies ([Klemke *et al*, 2002](#bib20){ref-type="other"}; [Ponti *et al*, 2005](#bib38){ref-type="other"}). Negative cases may represent T-cell neoplasms with rearrangement not in the gamma chain locus but rather in the V-II family locus ([McCarthy *et al*, 1992](#bib27){ref-type="other"}).

The diagnosis of MF is dependent on confirmatory tissue biopsy showing atypical skin-homing (epidermotropic) malignant T-helper memory phenotype (CD3+, CD4+, CD8−, CD45R0+) ([Fierro *et al*, 2001](#bib9){ref-type="other"}). MF is hypothesised to arise through a persistent antigenic stimulation, leading to an accumulation of skin-homing T-cells that are defective in Fas-mediated apoptotic programmed cell death ([Tan *et al*, 1974](#bib54){ref-type="other"}; [Nagasawa *et al*, 2004](#bib30){ref-type="other"}).

Although viruses are known to provide chronic immune stimulation, the findings of their association with MF are controversial ([Pancake *et al*, 1995](#bib35){ref-type="other"}; [Boni *et al*, 1996](#bib2){ref-type="other"}; [Nagore *et al*, 2000](#bib31){ref-type="other"}; [Herne *et al*, 2003](#bib13){ref-type="other"}). HTLV-1 is found in adult T-cell lymphoma and leukemia, and it has been implicated by several studies in CTCL ([Zucker-Franklin and Pancake, 1994](#bib63){ref-type="other"}; [Pancake *et al*, 1995](#bib35){ref-type="other"}; [Khan *et al*, 1996](#bib19){ref-type="other"}). However, others have not been able to confirm these findings ([Boni *et al*, 1996](#bib2){ref-type="other"}; [Wood *et al*, 1996](#bib60){ref-type="other"}). Epstein--Barr virus infection has also been previously implicated in several kinds of lymphomas, including peripheral T-cell lymphomas ([Shimakage *et al*, 2001](#bib48){ref-type="other"}; [Kanegane *et al*, 2002](#bib18){ref-type="other"}). Another study showed significantly higher CMV seropositivity rates in early-stage MF patients with normal immune systems and minimal skin involvement compared with control subjects ([Herne *et al*, 2003](#bib13){ref-type="other"}). Latent CMV and/or EBV infection could provide chronic antigen stimulation, induce T-cell proliferation, and adversely affect the apoptosis of skin-homing memory/helper T-cells.

It has also been suggested that bacterial agents, such as *Staphylococcus aureus* ([Tokura *et al*, 1992](#bib55){ref-type="other"}; [Jackow *et al*, 1997](#bib15){ref-type="other"}) or *Chlamydia pneumoniae* ([Abrams *et al*, 2001](#bib1){ref-type="other"}), might contribute to MF pathogenesis by acting as persistent antigens, thus exacerbating and/or perpetuating chronic T-cell expansion and cutaneous inflammation.

In Europe LD is caused by at least three species: *Borrelia burgdorferi sensu stricto, Borrelia afzelii* and *Borrelia garinii* ([Wilske, 2003](#bib59){ref-type="other"}). Among the dominant genospecies of Bb isolated in the FVG region is Borrelia afzelii, with its known tropism for the skin ([Ciceroni *et al*, 2001](#bib6){ref-type="other"}). The predominance of Borrelia afzelii in cutaneous lesions in LD has been already reported in several European countries ([Rijpkema *et al*, 1997](#bib39){ref-type="other"}; [Robertson *et al*, 1999](#bib40){ref-type="other"}; [Ruzic-Sabljic *et al*, 2000](#bib41){ref-type="other"}; [Ornstein *et al*, 2001](#bib33){ref-type="other"}). Strains of this intracellular pathogen can survive the adaptive immune response and persist in the skin despite a strong host antibody response ([Pachner *et al*, 2004](#bib34){ref-type="other"}). It has been postulated that borrelia interacts with the complement, inactivating complement regulatory proteins ([Kraiczy *et al*, 2001](#bib22){ref-type="other"}, [2002](#bib23){ref-type="other"}). Others have proved that Bb can hide in immunoprivileged sites ([de Koning *et al*, 1995](#bib8){ref-type="other"}; [Girschick *et al*, 1996](#bib11){ref-type="other"}). The antigen variation of the Bb outer membrane has also been discussed as a possible strategy for evading the immune response ([Seiler and Weis, 1996](#bib47){ref-type="other"}; [Zhang *et al*, 1997](#bib62){ref-type="other"}). Data from [Perticarari *et al* (2003)](#bib37){ref-type="other"} suggest that spirochaetes, including Bb, are able to induce apoptosis in lymphocytes, and that the cells involved are prevalently CD4.

The immune response in humans with LD is characterised by a type 1-like cytokine response with the production of gamma interferon (IFN-*γ*), but no interleukin (IL)-4 ([Forsberg *et al*, 1995](#bib10){ref-type="other"}; [Oksi *et al*, 1996](#bib32){ref-type="other"}). The type 1 (Th-1) immune response with high production of IFN-*γ* has been suggested to be the optimal response to all infections caused by intracellular microbes, such as Bb. It stimulates phagocytosis, the intracellular killing of microbes, antigen presentation to T cells and secretion of pro-inflammatory cytokines ([Shtrichman and Samuel, 2001](#bib49){ref-type="other"}). By clearing the pathogen, the Th-1 immune response would diminish further antigenic stimulation and allow a switch to a type 2 response by up-regulation of IL-4 ([Spellberg and Edwards, 2001](#bib52){ref-type="other"}). However, if the Th-1 response fails to completely clear the infection, a persistent antigenic stimulation might induce chronic Th-1 immune responses with IFN-*γ* production. Data from Widhe *et al* suggest that an initial Borrelia- specific IFN-*γ* response, followed by up-regulation of IL-4, is associated with non-chronic manifestations of LD, whereas a persistent IFN-*γ* response may lead to chronic LD ([Widhe *et al*, 2004](#bib58){ref-type="other"}).

Cutaneous lesions of MF are characterised by an epidermal Th1-type cytokine profile consisting of interleukin-2 and IFN-*γ*, whereas a type 2 cytokine production profile, consisting of IL-4, is more likely to occur in Sézary syndrome, the erythrodermic variant of MF ([Saed *et al*, 1994](#bib42){ref-type="other"}). Human IFN-*γ* -inducible protein 10 (IP-10) is secreted by IFN-*γ* -stimulated keratinocytes ([Sarris *et al*, 1997](#bib43){ref-type="other"}). It is chemotactic for CD4+ lymphocytes, a major component of MF lesions, and it probably accounts for the epidermotropism of CTCL ([Sarris *et al*, 1995](#bib44){ref-type="other"}).

The inflammatory infiltrate in both the early and late skin manifestations of Lyme borreliosis is mainly composed of CD68+ macrophages and CD45RO+ memory T cells, with a predominance of CD4+ helper T cells ([Silberer *et al*, 2000](#bib51){ref-type="other"}). Epidemiological data from many countries show that LD has increased significantly in incidence since the 1980s ([Jaenson, 1991](#bib16){ref-type="other"}; [Strle, 1999](#bib53){ref-type="other"}). The age-adjusted incidence rates of MF in our study area of 1 200 000 inhabitants were stable over the period of 6 years from 1995 to 2000, with the mean annual incidence of 1.9 cases per 100 000 person-years for males and 1.3 cases for females ([Zanier, 1995--2000](#bib61){ref-type="other"}).

Given these findings, we suggest that Bb could play a cofactor role in the aetiology of a proportion of CTCL, of which MF is the most common type. Recognition that a proportion of CTCL is related to Bb infection may also have important therapeutic implications. If a causal link between some cases of MF and Bb infection could be confirmed, a specific antibiotic therapy might be useful to improve the disease outcome even though MF is a T-cell lymphoma. In fact, there are already reports of primary cutaneous B-cell lymphomas responding to antibiotic therapy designed to treat Bb infection ([Hofbauer *et al*, 2001](#bib14){ref-type="other"}) even though the findings about the association between Bb and B-cell lymphomas are controversial ([Goodlad *et al*, 2000](#bib12){ref-type="other"}; [Kodama *et al*, 2005](#bib21){ref-type="other"}).

Another example of a tumour associated with chronic bacterial infection is gastric MALT (mucosa-associated lymphoid tissue) lymphoma, whose increased risk is clearly associated with *Helicobacter* (H) *pylori* infection, and which is the most frequent extranodal non-Hodgkin\'s lymphoma ([Van Krieken and Hoeve, 2000](#bib56){ref-type="other"}). *H. pylori* can induce antigen-specific T-cell responses at the gastric site of infection and, in some cases, drives a long-lasting polarised Th1 response with the development of specific T cells leading to the onset of low-grade gastric MALT lymphoma ([D\'Elios *et al*, 2003](#bib7){ref-type="other"}). The identification and eradication of *H. pylori* causes prolonged remission in more than 70% of patients with MALT lymphoma ([Boot and de Jong, 2002](#bib4){ref-type="other"}).

In conclusion, we have provided significant evidence to support the concept of antigen-driven lymphomagenesis in CTCL in response to Bb infection. We could hypothesise that in some individuals Bb might induce an antigen-specific long-lasting Th1 response leading to the accumulation of cutaneous CD4+ lymphocytes and their possible neoplastic transformation. A further assessment of the true incidence of Bb-associated CTCL is needed, together with further studies to assess the efficacy of antimicrobial therapy in treating this malignancy.
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![(**A**) The most common histological finding in our MF cases: a bandlike upper dermal infiltrate of lymphocytes, fibrosis of papillary dermis and the infiltration of lymphocytes into the epidermis (epidermotropism). (**B**) A detail of Pautrier\'s microabscesses. (**C**) CD4 positive immunohistochemistry. (**D**) CD20 negative immunohistochemistry.](94-6602997f1){#fig1}

![Examples of polymerase-chain reaction analysis of T-cell receptor-*γ* gene rearrangements. Lanes 1, 3 and 5 are MF samples positive for the rearrangements; lanes 2 and 4 are MF cases negative for the rearrangements. Lane 6 is molecular marker ladder.](94-6602997f2){#fig2}

###### 

Characteristics of patients with mycosis fungoides

  ------------------------------------------ --------------
  *Patients\' data*                          
   Number of MF samples                            83
   Average age (years); range                 65.5; 32--91
   Median age (years); 25--75th percentile     66; 58--75
   Sex male/female                               49/34
                                                    
  *Stage*                                    
   IA                                           33 (40%)
   IB                                           28 (34%)
   IIA                                          11 (13%)
   IIB                                           4 (5%)
   III                                           5 (6%)
   IVA                                             0
   IVB                                           2 (2%)
                                                    
  *Immunohistochemistry*                     
   CD3+                                          83/83
   CD4+                                          83/83
   CD8+                                          62/83
   CD20−                                          0/83
   Plasma cells                                   0/83
  ------------------------------------------ --------------
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